← Insider buys

DVA

DaVita Inc. · Healthcare

Insiders sold $454.3M of DaVita Inc. in the last 12 months and bought none

$0Bought, 12 mo
$454.3MSold, 12 mo
$11.9BMarket cap

DVA over the last year

No insider buys filed in this year

DVA after insider buys

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Congress

Members reported 9 trades in DVA since 2023.

Every filing

97 insider filings since 2016, newest first

DVASell

BERKSHIRE HATHAWAY INC · 10% owner

$36.5M−0.6%Aug 4
DVASell

Kathleen Alyce Waters · Chief Legal & Pub. Affairs Off

$3.2M−12.4%Jun 17
DVASell

Javier Rodriguez · Chief Executive Officer

$14.5M−7.6%Jun 17
DVASell

James O Hearty · Chief Compliance Officer

$2.9M−40.0%May 18
DVASell

David Paul Maughan · Chief Operating Officer, DKC

$4.1M−17.9%May 13
DVASell

Joel Ackerman · CFO and Treasurer

$9.9M−28.0%May 11
DVASell

James O Hearty · Chief Compliance Officer

$382K−6.0%May 8
DVASell

Berkshire Hathaway Inc · 10% owner

$182.9M−4.0%May 5
DVASell

Berkshire Hathaway Inc · 10% owner

$199.9M−5.0%Feb 2
DVASell

Javier Rodriguez · CEO

$9.9M−7.0%Sep 17
DVASell

Joel Ackerman · CFO, Treasuer

$10.7M−39.0%Aug 29
DVASell

Javier Rodriguez · CEO

$6.3M−4.0%Aug 28
DVASell

Michael David Staffieri · COO, DKC

$6.3M−17.0%Aug 19
DVASell

Kathleen Alyce Waters · Chief Legal, Pub. Affairs Off

$1.1M−9.0%Aug 15
DVASell

Barbara J Desoer · Director

$698K−31.0%May 14
DVASell

Javier Rodriguez · CEO

$9.5M−13.0%Feb 28
DVASell

Michael David Staffieri · COO, DKC

$3.5M−13.0%Feb 23
DVASell

Kathleen Alyce Waters · Chief Legal, Pub. Affairs Off

$1.4M−12.0%Feb 23
DVASell

James O Hearty · Chief Compliance Officer

$3.1M−56.0%Feb 20
DVASell

Kathleen Alyce Waters · Chief Legal, Pub. Affairs Off

$997K−11.0%Aug 24
DVASell

Javier Rodriguez · CEO

$1.7M−4.0%May 12
DVASell

James O Hearty · Chief Compliance Officer

$584K−15.0%May 12
DVASell

Phyllis R Yale · Director

$209K−14.0%May 12
DVASell

Kathleen Alyce Waters · Chief Legal, Pub. Affairs Off

$1.6M−15.0%May 12
DVASell

Barbara J Desoer · Director

$249K−15.0%May 12
DVASell

Charles Berg · Director

$108K−6.0%Mar 13
DVASell

Charles Berg · Director

$60K−3.0%Mar 2
DVABuy

John M Nehra · Director

$356K+7.0%Nov 1
DVASell

Barbara J Desoer · Director

$226K−16.0%Jun 6
DVASell

Paula A Price · Director

$80K−59.0%Feb 15
DVASell

Pamela M Arway · Director

$46K−2.0%Nov 23
DVASell

Pamela M Arway · Director

$49K−2.0%Aug 23
DVASell

Joel Ackerman · CFO and Treasurer

$5.0M−52.0%Aug 6
DVASell

Paula A Price · Director

$105K−68.0%Aug 6
DVASell

Phyllis R Yale · Director

$628K−35.0%Jun 23
DVASell

Pamela M Arway · Director

$47K−2.0%May 25
DVASell

Barbara J Desoer · Director

$242K−16.0%May 17
DVASell

James O Hearty · Chief Compliance Officer

$108K−6.0%May 5
DVASell

Javier Rodriguez · CEO

$3.3M−9.0%May 5
DVASell

Charles Berg · Director

$229K−9.0%May 5
DVASell

Kathleen Alyce Waters · Chief Legal, Pub. Affairs Off

$626K−7.0%May 4
DVASell

Pamela M Arway · Director

$48K−2.0%Mar 22
DVASell

Michael David Staffieri · COO, DKC

$2.7M−17.0%Dec 2
DVASell

Pamela M Arway · Director

$46K−2.0%Nov 23
DVASell

Pamela M Arway · Director

$818K−27.0%Nov 17
DVASell

Barbara J Desoer · Director

$154K−12.0%Nov 17
DVASell

Kathleen Alyce Waters · General Counsel

$1.1M−15.0%Nov 12
DVASell

Leanne M Zumwalt · Group VP, Government Affairs

$332K−13.0%Sep 22
DVASell

Berkshire Hathaway Inc · 10% owner

$176.0M−5.0%Sep 21
DVASell

Weschler, R. Ted · Member of 10% owner group

$193.6M−5.0%Sep 21
About DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.